Krka Singles Out Launch Opportunities As Prescription Sales Tumble
Prescription Pharmaceutical Sales Fall By 12%
Slovenian firm Krka saw sales and profits down in the first quarter of 2021 as operations normalized to some degree following an extraordinary Q1 last year.